| acc1101 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1102 |
EGFR |
phosphorylation |
Tyr1068 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1103 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1104 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1105 |
MEK1 |
phosphorylation |
Ser217 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1106 |
MEK1 |
phosphorylation |
Ser221 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1107 |
MEK2 |
phosphorylation |
Ser222 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1108 |
MEK2 |
phosphorylation |
Ser226 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1109 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1110 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1111 |
ERK2 |
phosphorylation |
Thr185 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1112 |
ERK2 |
phosphorylation |
Tyr187 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1113 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1114 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H1975 |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1115 |
MEK1 |
phosphorylation |
Ser217 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1116 |
MEK1 |
phosphorylation |
Ser221 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1117 |
MEK2 |
phosphorylation |
Ser222 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1118 |
MEK2 |
phosphorylation |
Ser226 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1119 |
ERK1 |
phosphorylation |
Thr202 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1120 |
ERK1 |
phosphorylation |
Tyr204 |
human |
Lung Cancer |
PC-9/GR |
Gefitinib + Lovastatin |
Associated |
4.0 (Moderate) |
29215723
|
| acc1121 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
SK-OV-3 |
PJ-34 |
Associated |
4.0 (Moderate) |
21821012
|
| acc1122 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
SK-OV-3 |
3-AB |
Associated |
4.0 (Moderate) |
21821012
|
| acc1123 |
AKT |
phosphorylation |
Ser473 |
human |
Osteosarcoma |
U2OS |
PJ-34 |
Associated |
4.0 (Moderate) |
21821012
|
| acc1124 |
AKT |
phosphorylation |
Ser473 |
human |
Osteosarcoma |
U2OS |
3-AB |
Associated |
4.0 (Moderate) |
21821012
|
| acc1125 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H358 |
PJ-34 |
Associated |
4.0 (Moderate) |
21821012
|
| acc1126 |
AKT |
phosphorylation |
Ser473 |
human |
Lung Cancer |
H358 |
3-AB |
Associated |
4.0 (Moderate) |
21821012
|
| acc1127 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Pancreas Cancer |
AsPC-1 |
Bazedoxifene |
Associated |
4.0 (Moderate) |
27535971
|
| acc1128 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Pancreas Cancer |
HPAF-2 |
Bazedoxifene |
Associated |
4.0 (Moderate) |
27535971
|
| acc1129 |
STAT3 |
phosphorylation |
Tyr705 |
human |
Pancreas Cancer |
PANC-1 |
Bazedoxifene |
Associated |
4.0 (Moderate) |
27535971
|
| acc1130 |
AKT |
phosphorylation |
Ser473 |
human |
Gastric Cancer |
MKN45 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1131 |
AKT |
phosphorylation |
Ser473 |
human |
Gastric Cancer |
SGC7901 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1132 |
p70S6K |
phosphorylation |
Thr421 |
human |
Gastric Cancer |
MKN45 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1133 |
p70S6K |
phosphorylation |
Thr421 |
human |
Gastric Cancer |
SGC7901 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1134 |
p70S6K |
phosphorylation |
Ser424 |
human |
Gastric Cancer |
MKN45 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1135 |
p70S6K |
phosphorylation |
Ser424 |
human |
Gastric Cancer |
SGC7901 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1136 |
4EBP1 |
phosphorylation |
Thr70 |
human |
Gastric Cancer |
MKN45 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1137 |
4EBP1 |
phosphorylation |
Thr70 |
human |
Gastric Cancer |
SGC7901 |
5-aza |
Impairing |
5.0 (High)
|
18622747
|
| acc1138 |
c-Raf |
phosphorylation |
Ser43 |
human |
Hepatocellular Carcinoma |
Hep3B |
Vitamin K1 + Sorafenib |
Associated |
4.0 (Moderate) |
21734462
|
| acc1139 |
c-Raf |
phosphorylation |
Ser259 |
human |
Hepatocellular Carcinoma |
Hep3B |
Vitamin K1 + Sorafenib |
Associated |
4.0 (Moderate) |
21734462
|
| acc1140 |
c-Met |
phosphorylation |
Tyr1349 |
human |
Hepatocellular Carcinoma |
Hep3B |
Vitamin K1 + Sorafenib |
Associated |
4.0 (Moderate) |
21734462
|
| acc1141 |
AKT |
phosphorylation |
Thr308 |
human |
Ovarian Cancer |
HEY |
Lysophosphatidic acid (LPA) |
Associated |
4.0 (Moderate) |
12181443
|
| acc1142 |
AKT |
phosphorylation |
Thr308 |
human |
Ovarian Cancer |
HEY |
Sphingosine-1-phosphate |
Associated |
4.0 (Moderate) |
12181443
|
| acc1143 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
HEY |
Lysophosphatidic acid (LPA) |
Associated |
4.0 (Moderate) |
12181443
|
| acc1144 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
HEY |
Sphingosine-1-phosphate |
Associated |
4.0 (Moderate) |
12181443
|
| acc1145 |
AKT |
phosphorylation |
Thr308 |
human |
Ovarian Cancer |
HEY |
Paclitaxel |
Impairing |
5.0 (High)
|
12181443
|
| acc1146 |
AKT |
phosphorylation |
Ser473 |
human |
Ovarian Cancer |
HEY |
Paclitaxel |
Impairing |
5.0 (High)
|
12181443
|
| acc1147 |
AKT |
phosphorylation |
Ser473 |
human |
Myeloma |
XG-6 |
mAVE1642 |
Associated |
2.0 (Low)
|
16951388
|
| acc1148 |
EGFR |
phosphorylation |
unclear |
human |
Hepatocellular Carcinoma |
HepG2 |
MCI-186 |
Associated |
4.0 (Moderate) |
15868956
|
| acc1149 |
EGFR |
phosphorylation |
unclear |
human |
Mesothelioma |
MSTO-211H |
MCI-186 |
Associated |
4.0 (Moderate) |
15868956
|
| acc1150 |
EGFR |
phosphorylation |
unclear |
human |
Gastric Cancer |
TMK-1 |
MCI-186 |
Associated |
4.0 (Moderate) |
15868956
|